Build, Run, Own is Enquirer Consulting Group's fixed four-month engagement: we design, staff and run a complete outbound sales business unit for a US medical or pharma company, prove it on live numbers, then hand the working unit and a trained operator to your team to own. The full explanation is on the Build, Run, Own page.
FAQ
Frequently asked questions
Direct answers, in the words buyers actually use. Where a fuller page exists, we link to it. If your question is not here, ask us and we will answer it the same way.
THE MODEL
The model.
Enquirer Consulting Group does this as its flagship practice: custom outbound sales engines for US pharmaceutical and pharma services companies, built and proven over four months, then handed over. Healthcare-literate lead generation agencies also operate in this space on a retainer model; the difference is what you own at the end. The full comparison of all five options is on our 2026 comparison page.
An agency can rent you the capacity; Enquirer Consulting Group builds you the operation. We design, staff and run the outbound side of your sales operation, prove it on live numbers, and hand it over. Where the gaps run wider than top of funnel, the engagement covers the surrounding disciplines too, scoped to what you actually need.
No. The engine produces qualified conversations; your team closes them. Where a client has no one to receive the conversations, the engagement includes sourcing and training the GTM operator who will.
Because the engagement is scoped to your weak points, and a published number would be wrong in both directions. Pricing is presented live on a call, once we understand the scope. We hold that line even when it costs us a click.
THE ENGINE
The engine.
The system that produces qualified sales conversations on schedule instead of by luck: a targeting and data layer, messaging written for one real buyer, protected sending infrastructure, LinkedIn outreach alongside email, reply routing to a human, and reporting tied to pipeline. A campaign runs and stops. An engine compounds.
Not the way we run it. Sending happens from separate warmed domains, never your corporate domain, with deliverability managed daily. We hold bounce rates under 0.5% on live sending.
Sequences are built on your approved claims and reviewed with you before anything sends. The engine's job is reach and relevance; it does not improvise product claims your compliance team has not seen.
No. The engine runs on business contact data, the people who buy at medical and pharma companies, not patient data. Messaging is built on your approved claims, and sending runs from separate domains so your corporate infrastructure stays untouched.
First conversations typically land in the first weeks, because day-one capacity comes from warmed assets rather than a cold start. Markets differ, and the readiness review is where we tell you what yours can support.
FIT AND SECTOR
Fit and sector.
An established US medical or pharma company, including devices, imaging, diagnostics and pharma services, with real revenue and a sales motion that still runs on relationships, trade shows and referrals. One senior owner of the growth decision, and outbound either switched off or stuck in manual prospecting.
Yes, imaging is our most proven practice, with named on-camera results. See outbound sales for US medical imaging companies and lead generation for medical device companies.
The flagship practice is US medical and pharma, and the proof lives there. The model itself is sector-agnostic, and we take established B2B companies outside the sector case by case.
RESULTS AND PROOF
Results and proof.
Lifetime across our client campaigns: 3,500+ qualified conversations generated and 100,000+ decision makers reached. On recent US medical campaigns specifically: 260+ qualified conversations from under 10,000 targeted LinkedIn invitations, connection acceptance between 27% and 36%, and on a single seat, 97 qualified conversations at 36% acceptance. For one named radiology group, 164 qualified conversations across three seats. All as of June 2026, achieved results on strong campaigns, not projections. Since we started running their outreach, our clients have sold over $1M in new business, a client-reported figure. The qualified-conversation metric is defined on our resources page.
A positive or interested reply. Not a booked meeting, not a deal. We label our numbers precisely because this market checks, and you should hold anyone you evaluate to the same standard.
You can watch two of them now: Tim Rath of Innovative Radiology and Paul Smaldone of Innovative Medical tell the story on camera on our resources page. And we will set up a direct reference call on request while you evaluate us, not only once a deal is underway.
WORKING WITH US
Working with us.
You give us a short read on how you grow today; we return a specific, one-page view of where an outbound engine would add the most, whichever partner model you choose. No deck, no pitch.
One accountable team with one point of contact, founded and led by the people on the company page. The specialist network behind the disciplines is named on the partners page, and you never manage it.
Discovery, in the plain sense. We ask how you grow today, where it stalls, and what you have tried. If the fit is wrong, we say so on that call.
Ask the question directly.
If your question is not answered here, send it over. You get a direct answer, not a sequence.
Get your free readiness reviewOr contact us.